Genomic modifiers of malignant and neurodevelopmental phenotypes in individuals with PTEN hamartoma tumor syndrome.
Saved in:
| Title: | Genomic modifiers of malignant and neurodevelopmental phenotypes in individuals with PTEN hamartoma tumor syndrome. |
|---|---|
| Authors: | Yehia L; Genomic Medicine Institute, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, USA.; Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA., Li L; Cancer Sciences, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, USA., Idumah G; Cancer Sciences, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, USA., Frazier TW; Autism Speaks, Cleveland, OH, USA.; Department of Psychology, John Carroll University, University Heights, OH, USA.; Departments of Pediatrics and Psychiatry, SUNY Upstate Medical University, Syracuse, NY, USA., Makarov V; Cancer Sciences, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, USA., Bose A; IBM Research, Yorktown Heights, NY, USA., Parida L; IBM Research, Yorktown Heights, NY, USA., Hardan A; Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, CA, USA., Martinez-Agosto JA; Departments of Pediatrics and Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Ritter DM; Division of Neurology, Cincinnati Children's Hospital Medical Center; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA., Sahin M; Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Eng C; Genomic Medicine Institute, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, USA.; Center for Personalized Genetic Healthcare, Community Care, Cleveland Clinic, Cleveland, OH, USA.; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.; Germline High Risk Cancer Focus Group, CASE Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Ni Y; Cancer Sciences, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, USA. niy@ccf.org.; School of Medicine, Case Western Reserve University, Cleveland, OH, USA. niy@ccf.org. |
| Corporate Authors: | Developmental Synaptopathies Consortium |
| Source: | NPJ genomic medicine [NPJ Genom Med] 2026 Mar 17; Vol. 11 (1). Date of Electronic Publication: 2026 Mar 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature in partnership with the Center of Excellence in Genomic Medicine Research at King Abdulaziz University Country of Publication: England NLM ID: 101685193 Publication Model: Electronic Cited Medium: Internet ISSN: 2056-7944 (Electronic) Linking ISSN: 20567944 NLM ISO Abbreviation: NPJ Genom Med Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2056-7944 |
|---|---|
| DOI: | 10.1038/s41525-026-00556-1 |
